16 results
165 |
Flower-shaped lymphocytes in CD5+ diffuse large B-cell lymphoma’s leukemic phase
Verónica Roldán Galiacho, Paula Zoco Gallardo, Laura Zaldumbide Dueñas, Bernabé Dávila De Las Fuentes, Juan Carlos García-Ruiz
KMSID: 1516085680 Blood Res. 2023;58(4):165-165. Published online 2023 October 19 DOI: http://dx.doi.org/10.5045/br.2023.2023178 | |
166 |
Recent advances in cellular immunotherapy for lymphoid malignancies
Haerim Chung, Hyunsoo Cho
KMSID: 1516085681 Blood Res. 2023;58(4):166-172. Published online 2023 November 15 DOI: http://dx.doi.org/10.5045/br.2023.2023177 | |
173 |
Abdominal aortic calcification in patients newly diagnosed with essential thrombocythemia
Myung-Won Lee, Jeong Suk Koh, Sora Kang, Hyewon Ryu, Ik-Chan Song, Hyo-Jin Lee, Hwan-Jung Yun, Seon Young Kim, Seong Soo Kim, Deog-Yeon Jo
KMSID: 1516085683 Blood Res. 2023;58(4):173-180. Published online 2023 October 19 DOI: http://dx.doi.org/10.5045/br.2023.2023125 | |
181 |
Treatment outcome and prognostic factors in relapsed pediatric acute myeloid leukemia
Jung Hwan Lee, Hee Young Ju, Ju Kyung Hyun, So Jin Kim, Hee Won Cho, Jae Kyung Lee, Ji Won Lee, Ki Woong Sung, Keon Hee Yoo
KMSID: 1516085682 Blood Res. 2023;58(4):181-186. Published online 2023 November 6 DOI: http://dx.doi.org/10.5045/br.2023.2023152 | |
187 |
Correlation between red blood cell distribution width/platelet count and prognosis of newly diagnosed diffuse large B-cell lymphoma
Xiaobo Liu, Yanliang Bai, Ying Liu, Weiya Li, Yabin Cui, Jinhui Xu, Xingjun Xiao, Xiaona Niu, Kai Sun
KMSID: 1516085684 Blood Res. 2023;58(4):187-193. Published online 2023 November 30 DOI: http://dx.doi.org/10.5045/br.2023.2023156 | |
194 |
A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study
Seok Jin Kim, Young Rok Do, Ho-Sup Lee, Won-Sik Lee, Jee Hyun Kong, Jae-Yong Kwak, Hyeon-Seok Eom, Joon Ho Moon, Jun Ho Yi, Jeong-Ok Lee, Jae-Cheol Jo, Deok-Hwan Yang
KMSID: 1516085679 Blood Res. 2023;58(4):194-200. Published online 2023 November 30 DOI: http://dx.doi.org/10.5045/br.2023.2023206 | |
201 |
The association of pro-oxidant/antioxidant balance and blood parameters in patients with beta-thalassemia major: a cross-sectional study
Maryam Parvizi, Maryam Deldadeh Moghaddam, Shiva Nazari, Hami Ashraf, Maryam Kazemi Aghdam
KMSID: 1516085685 Blood Res. 2023;58(4):201-207. Published online 2023 December 31 DOI: http://dx.doi.org/10.5045/br.2023.2023174 | |
208 |
A retrospective analysis of ibrutinib outcomes in relapsed or refractory mantle cell lymphoma
Yong-Pyo Lee, Ye Ji Jung, Junhun Cho, Young Hyeh Ko, Won Seog Kim, Seok Jin Kim, Sang Eun Yoon
KMSID: 1516085686 Blood Res. 2023;58(4):208-220. Published online 2023 December 31 DOI: http://dx.doi.org/10.5045/br.2023.2023208 | |
221 |
Incidental abdominal computed tomography findings in patients newly diagnosed with Philadelphia-negative myeloproliferative neoplasm
Ik-Chan Song, Jeong Suk Koh, Sora Kang, Myung-Won Lee, Kyung Sook Shin, Deog-Yeon Jo
KMSID: 1516085687 Blood Res. 2023;58(4):221-224. Published online 2023 October 19 DOI: http://dx.doi.org/10.5045/br.2023.2023049 | |
224 |
Clinically relevant core genes for hematologic malignancies in clinical NGS panel testing
Ju Sun Song
KMSID: 1516085689 Blood Res. 2023;58(4):224-228. Published online 2023 November 6 DOI: http://dx.doi.org/10.5045/br.2023.2023196 | |
228 |
TP53 mutation is a high-risk factor for Richter’s syndrome based on circulating tumor DNA
Hee Sue Park, Bo Ra Son, Seung Myoung Son, Jihyun Kwon
KMSID: 1516085688 Blood Res. 2023;58(4):228-231. Published online 2023 November 6 DOI: http://dx.doi.org/10.5045/br.2023.2023189 | |
231 |
T-cell large granular lymphocytic leukemia with low-grade bone marrow involvement complicated by acquired pure red cell aplasia
Bernhard Strasser, Sonja Heibl, Josef Thaler, Alexander Haushofer
KMSID: 1516085690 Blood Res. 2023;58(4):231-234. Published online 2023 November 15 DOI: http://dx.doi.org/10.5045/br.2023.2023141 | |
234 |
Ibrutinib combined with gemcitabine-vinorelbine for primary refractory non-Hodgkin lymphoma
Muruvvet Seda Aydin, Esra Cengiz, Ferda Can, Simten Dagdas, Imdat Dilek, Gulsum Ozet
KMSID: 1516085691 Blood Res. 2023;58(4):234-237. Published online 2023 November 15 DOI: http://dx.doi.org/10.5045/br.2023.2023182 | |
237 |
Successful recovery of poor graft function by administration of romiplostim in a multiple myeloma case with poor graft function following autologous stem cell transplantation
Jeongmin Yim, Sung-Soo Park, Jong-Mi Lee, Jae-Ho Yoon, Hee-Je Kim, Chang-Ki Min
KMSID: 1516085692 Blood Res. 2023;58(4):237-240. Published online 2023 November 30 DOI: http://dx.doi.org/10.5045/br.2023.2023185 | |
240 |
Clinico-pathological features and treatment outcomes of high-grade B cell lymphoma—a tertiary cancer center experience
Anindya Mukherjee, Sujay Rainchwar, Aakanksha Singh, Rohan Halder, Pritish Chandra Patra, Rayaz Ahmed, Dinesh Bhurani, Narendra Agrawal
KMSID: 1516085693 Blood Res. 2023;58(4):240-242. Published online 2023 November 30 DOI: http://dx.doi.org/10.5045/br.2023.2023169 | |
242 |
Lenalidomide as a treatment for patients with AL amyloidosis and cardiac involvement
Seo Yoon Jang, Ja Min Byun, Sung-Soo Yoon, Jin Chul Paeng, Seung-Pyo Lee, Youngil Koh
KMSID: 1516085694 Blood Res. 2023;58(4):242-245. Published online 2023 December 31 DOI: http://dx.doi.org/10.5045/br.2023.2023194 | |